Knockdown of MRN complex decreases HBV cccDNA level. حسب Kaitao Zhao (3617825)

Knockdown of MRN complex decreases HBV cccDNA level. حسب Kaitao Zhao (3617825)

The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. حسب Kaitao Zhao (3617825)

The significant decrease in GLT-1 levels observed in the nucleus accumbens of rats that had consumed morphine for fifty-six days was completely reversed by the co-administration of NAC (40 mg/kg/day, i.p.) and ibudilast (7.5 mg/kg/day, i.p.). حسب María Elena Quintanilla (8068691)

Significant decrease of the coiled-coil score in the double proline-substituted CAHS3 mutant. حسب Akihiro Tanaka (342394)

Tumor growth increases the frequency and number of regulatory T cells in the spleen of obese mice without affecting their phenotype. حسب Aleida Núñez-Ruiz (12463062)

الموضوعات:

Expression of <i>pdcB</i> affects known c-di-GMP regulated processes. حسب Leila M. Reyes Ruiz (6690206)

الموضوعات:

Nitrate and nitrite treatment did not adversely affect multiple parameters of health but nitrate treatment significantly decreased movement following a startle. حسب Manuel García-Jaramillo (9930572)

Phase 2 significant effects. حسب Wendy C. Crone (2262169)

Phase 1 significant effects. حسب Wendy C. Crone (2262169)

Feeding and starvation affect the proportion and cell cycle activity of Vasa2+/Piwi1+ cells. حسب Eudald Pascual-Carreras (12115380)

Decrease of injuries. حسب Petr Fulin (8380320)

الموضوعات:

Decreasing laminin levels in BCs does not affect their migration. حسب Ester Molina López (16462735)

Networks of affect states: Significant paths. حسب Anna Kuranova (8460411)

"…<p>In this figure, affect states networks are visualized for the Stable and the Increase groups. …"

Socio-demographic and medical characteristics of patients with liver cancer. حسب Ayana Ablayeva (22103708)

الموضوعات:

Data cleaning and preparation algorithm. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. حسب Ayana Ablayeva (22103708)

الموضوعات:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. حسب Ayana Ablayeva (22103708)

الموضوعات: